A comprehensive view of Regeneron Pharmaceuticals Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia: Regeneron Pharmaceuticals Receives Patent for 'Non-human animals capable of DH-DH rearrangement in the immunoglobulin heavy chain coding sequences'
Published: December 02, 2022 by Australian Government
Australia Patent: Regeneron Pharmaceuticals Files Application for 'Methods and systems for analysis of receptor interaction'
Published: December 02, 2022 by Australian Government
Australia Patent: Sanofi Biotechnology, Regeneron Pharmaceuticals File Application for 'Methods for treating atopic dermatitis by administering an IL-4R antagonist'
Published: December 02, 2022 by Australian Government
Australia Patent: Regeneron Pharmaceuticals Files Application for 'Viral clearance by low pH hold'
Published: December 02, 2022 by Australian Government
Australia: Regeneron Pharmaceuticals Receives Patent for 'Non-human animals having a humanized Lymphocyte-activation gene 3'
Published: December 02, 2022 by Australian Government

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count